Elsevier

Matrix Biology

Volume 17, Issue 5, October 1998, Pages 361-369
Matrix Biology

Regular paper
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: Relationship to clinical severity and indications on the role of intracellular sulfate production

https://doi.org/10.1016/S0945-053X(98)90088-9Get rights and content

Abstract

Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene have been associated with a family of chondrodysplasias that includes diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2) and the lethal condition achondrogenesis type 1B (ACG1B). There is a correlation between the nature of the mutations and the clinical phenotype, but our understanding of the pathophysiology of the disorder, which involves defective sulfation of cartilage proteoglycans, is far from complete. To evaluate the degree of proteoglycan undersulfation in vivo, we have extracted chondroitin sulfate proteoglycans from cartilage of twelve patients with sulfate transporter chondrodysplasias and analyzed their disaccharide composition by HPLC after digestion with chondroitinase ABC. The amount of non-sulfated disaccharide was elevated in patients' samples (controls, 5.5% ± 2.8 (n = 10); patients, 11% to 77%), the highest amount being present in ACG1B patients, indicating that undersulfation of chondroitin sulfate proteoglycans occurs in cartilage in vivo and is correlated with the clinical severity. To investigate further the biochemical mechanisms responsible for the translation of genotype to phenotype, we have studied fibroblast cultures of patients with DTD, AO2 and ACG1B, and controls, by double-labelling with [35S]sulfate and [3H]glucosamine. The incorporation of extracellular sulfate, estimated by the 35S/3H ratio in proteoglycans, was reduced in all patients' cells, with ACG1B cells showing the lowest values. However, disaccharide analysis of chondroitin sulfate proteoglycans showed that these were normally sulfated or only moderately undersulfated; marked undersulfation was observed only after addition of the artificial glycosaminoglycan-chain initiator, β-D-xyloside, to the culture medium. These results suggest that, while utilization of extracellular sulfate is impaired, fibroblasts can replenish their intracellular sulfate pool by oxidizing sulfur-containing compounds (such as cysteine) and thus partially rescue PG sulfation under basal conditions. This rescue pathway becomes insufficient when GAG synthesis rate is stimulated by β-D-xyloside. These findings may explain why phenotypic consequences of DTDST mutations are restricted to cartilage, a tissue with high GAG synthesis rate and poor vascular supply, and imply that pharmacological therapy aimed at restoring the intracellular sulfate pool might improve PG sulfation in DTD and related disorders.

References (24)

Cited by (57)

  • Biology of Proteoglycans and Associated Glycosaminoglycans

    2021, Comprehensive Glycoscience: Second Edition
  • Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine

    2021, Biochemical Pharmacology
    Citation Excerpt :

    Nowadays patients are treated by corrective orthopaedic surgery and physiotherapy, but no pharmacological treatment is available. Since a correlation between the severity of the clinical phenotype and cartilage PG undersulfation was demonstrated in SLC26A2 chondrodysplasias [4], a pharmacological strategy targeted at increasing cartilage PG sulfation would likely result in an improvement of the skeletal phenotype. In chondrocytes, beyond extracellular sulfate uptake, a small amount of sulfate may come from the catabolism of sulfur-containing amino acids such as methionine and cysteine.

  • Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification

    2019, Matrix Biology
    Citation Excerpt :

    The released chondrocytes were plated and cultured in DMEM with 10% foetal calf serum (FCS) (EuroClone) at 37 °C in a humidified atmosphere containing 5% CO2. Chondrocyte cultures were preincubated with or without 1 mM p-nitrophenyl β-d-xylopyranoside (Sigma-Aldrich) in minimal essential medium (MEM) (Sigma-Aldrich) containing 250 μM cold Na2SO4 without FCS at 37 °C in 5% CO2 for 2 h. Cells were then labelled with 50 μCi/ml Na2[35SO4] (38.8–59.2 TBq/mmol, PerkinElmer) in the same medium for 24 h as described previously [40]. At the end of the labelling period, an equal volume of 100 mM sodium acetate buffer, pH 5.8, containing 8 M urea, 4% Triton X-100, 20 mM EDTA, 20 mM N-ethylmalemide (NEM), 0.1 M 6-aminocaproic acid and 1 mM phenylmethylsulfonyl fluoride (PMSF) was added to the medium.

  • Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias

    2019, EBioMedicine
    Citation Excerpt :

    Safranin O, a cationic dye showing affinity to polyanionic sulfated molecules, was used to reveal the sulfation degree of the ECM. Consistent with previous studies on human ACG1B and AO2 [48], the cartilage matrix was less intensely stained by Safranin O in slc26a2−/− growth plates than slc26a2+/− controls, which indicated matrix undersulfation (Fig. 1I). The morphology of slc26a2−/− growth plates was severely disrupted, showing shortened length, disorganized chondrocyte alignment and decreased cellularity (Fig. 1I-K).

View all citing articles on Scopus
View full text